PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Department of Radiology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Department of Immunology, Ophthalmology and ORL, Complutense University School of Medicine, Madrid, Spain; 12 de Octubre Health Research Institute (IMAS12), Madrid, Spain.\', \'Department of Immunology, Ophthalmology and ORL, Complutense University School of Medicine, Madrid, Spain; 12 de Octubre Health Research Institute (IMAS12), Madrid, Spain; Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.\', \'Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Division of Nutrition, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Metabolic Diseases Research Unit (UIEM), Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Liver Fibrosis and Nutrition lab (LFN-Lab), Mexico City, Mexico; MICTLÁN Network: mechanisms of liver injury, cell death and translational nutrition in liver diseases-research network.\', \'Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Liver Fibrosis and Nutrition lab (LFN-Lab), Mexico City, Mexico; MICTLÁN Network: mechanisms of liver injury, cell death and translational nutrition in liver diseases-research network. Electronic address: ricardomacro@yahoo.com.mx.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1590-8658(21)00034-710.1016/j.dld.2021.01.019
?:doi
?:hasPublicationType
?:journal
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
is ?:pmid of
?:pmid
?:pmid
  • 33551355
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33551355>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33551355>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all